<!DOCTYPE html><html lang="en"><head><meta charset="UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width,initial-scale=1"><title>NEXUS - Home</title><link rel="shortcut icon" href="/assets/images//sport_soccer.png" type="image/x-icon"><link rel="shortcut icon" href="/assets//images/favicon.webp" type="image/webp"><meta name="description" content="Home Page"><meta name="keywords" content="Home,Page"><link rel="stylesheet" href="/assets//styles/style.css"></head><body id="pagetop" data-role="home"><main><header><h1><a href="/"><img src="/assets/images/nexus-logo.svg" alt=""></a></h1></header><div id="popupContent"><div><div class="popupMain"><a class="popupClose" href="javascript:;"><img src="/assets/images/close-icon.svg" alt=""></a><div class="popupInner"><div class="popupHead"><img src="" alt=""><h2></h2></div><div class="popupBody"></div><div class="popupFooter"><div class="footTextAppend"></div><div class="buttonsAppend"></div></div></div></div></div></div><section><summary>To access Prescribing Information please select your country</summary><div class="border-radius-content bg-orange offset-md-2 col-md-8"><p>For reference purpose only; follow your Prescribing Information (PI) indications as mandated by local regulations.</p></div><div class="container"><div class="row"><div class="offset-md-2 col-md-8"><div class="countryList pt-3"><div class="row"><div class="col-lg-4"><ul><li><a href="javascript:;" data-popup-content="&lt;p&gt;La información para prescribir de nuestros productos se encuentra disponible escaneando el código QR o ingresando en: &lt;a href=&quot;https://gskpro.com/es-ar/productos/&quot; target=&quot;_blank&quot;&gt;https://gskpro.com/es-ar/productos/&lt;/a&gt;&lt;/p&gt;&lt;p&gt;Para mayor información de nuestros productos o solicitar información médica puede ingresar en: &lt;a href=&quot;https://gskpro.com/es-ar/&quot; target=&quot;_blank&quot;&gt;https://gskpro.com/es-ar/&lt;/a&gt;&lt;/p&gt;&lt;p&gt;Para reportar eventos adversos de nuestros productos envíe un mail &lt;a href=&quot;mailto:WW.GSKAEReportingAmericas@gsk.com&quot; target=&quot;_blank&quot;&gt;WW.GSKAEReportingAmericas@gsk.com&lt;/a&gt;&lt;/p&gt;&lt;p&gt;GSK BIOPHARMA ARGENTINA S.A. – Av. Del Libertador 7202, Piso 4 (1429) – Ciudad de Buenos Aires&lt;/p&gt;&lt;p&gt;Este material está destinado para el uso exclusivo de los médicos/profesionales de la salud&lt;/p&gt;" data-popup-buttons="&lt;a class=&quot;button&quot; href=&quot;https://gskpro.com/content/dam/global/hcpportal/es_AR/pdfs/homepage/products/Nucala/PI-Nucala-AI-Argentina.pdf&quot; target=&quot;_blank&quot;&gt;&lt;span&gt;Nucala Polvo&lt;/span&gt; &lt;img src=&quot;assets/images/white-arrow.svg&quot; /&gt;&lt;/a&gt;&lt;a class=&quot;button&quot; href=&quot;https://gskpro.com/content/dam/global/hcpportal/es_AR/pdfs/homepage/products/Nucala/ip_nucala_fda-sptiembre-2019.pdf&quot; target=&quot;_blank&quot;&gt;&lt;span&gt;Nucala Solucion Inyectable&lt;/span&gt; &lt;img src=&quot;assets/images/white-arrow.svg&quot; /&gt;&lt;/a&gt;" data-footbutton-text="&lt;h3&gt;For Prescribing Information&lt;/h3&gt;&lt;p&gt;To view or download click on the below buttons for each product.&lt;/p&gt;"><img src="/assets/images/argentina.svg" alt=""><span>Argentina </span><img src="/assets/images/arrow-icon.svg" alt=""></a></li><li><a href="javascript:;" data-popup-content="&lt;p&gt;To report Adverse Event/s associated with the use of GSK product/s, please contact us via &lt;a target=&quot;_blank&quot; href=&quot;mailto:gulf.safety@gsk.com&quot;&gt;gulf.safety@gsk.com&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;To report quality complaint/s associated with the use of GSK product/s, please contact us via &lt;a target=&quot;_blank&quot; href=&quot;mailto:Gulf.ProductQualityComplaints@gsk.com&quot;&gt;Gulf.ProductQualityComplaints@gsk.com&lt;/a&gt;&lt;/p&gt;&lt;p&gt;For more information, please refer to the prescribing information or contact GlaxoSmithKline via &lt;a target=&quot;_blank&quot; href=&quot;mailto:gcc.medinfo@gsk.com&quot;&gt;gcc.medinfo@gsk.com&lt;/a&gt;.&lt;/p&gt;" data-popup-buttons="&lt;a class=&quot;button&quot; href=&quot;https://gskpro.com/content/dam/global/hcpportal/en_XG/products/nucala_mt/pdf/pi_nucala_uae_oman_qatar_kuwait_and_bahrain_pi_9494.pdf&quot; target=&quot;_blank&quot;&gt;&lt;span&gt;Nucala Vial&lt;/span&gt; &lt;img src=&quot;assets/images/white-arrow.svg&quot; /&gt;&lt;/a&gt;&lt;a class=&quot;button&quot; href=&quot;https://gskpro.com/content/dam/global/hcpportal/en_XG/products/nucala_mt/pdf/updated_nucala_pi_for_triple_therapy_indication_uae_oman_bahrain_and_qatar_july_23.pdf&quot; target=&quot;_blank&quot;&gt;&lt;span&gt;Nucala PFP/PFS&lt;/span&gt; &lt;img src=&quot;assets/images/white-arrow.svg&quot; /&gt;&lt;/a&gt;" data-footbutton-text="&lt;h3&gt;For Prescribing Information&lt;/h3&gt;&lt;p&gt;To view or download click on the below buttons for each product.&lt;/p&gt;"><img src="/assets/images/bahrain.svg" alt=""><span>Bahrain </span><img src="/assets/images/arrow-icon.svg" alt=""></a></li><li><a href="javascript:;" data-popup-content="&lt;p&gt;Este material é de propriedade da GSK, a reprodução deste é proibida sem o consentimento da empresa.&lt;/p&gt;&lt;p&gt;Informação destinada exclusivamente para profissionais de saúde habilitados a prescrever ou dispensar medicamentos.&lt;/p&gt;&lt;p&gt;Recomenda-se a leitura da bula do produto, antes da prescrição de qualquer medicamento/vacina.&lt;/p&gt;&lt;p&gt;Mais informações à disposição, sob solicitação ao Departamento de Informações Médicas (DDG 0800 701 2233 ou &lt;a href=&quot;mailto:medinfo@gsk.com&quot; target=&quot;_blank&quot;&gt;medinfo@gsk.com&lt;/a&gt;).&lt;/p&gt;&lt;p&gt;Para notificar informações de segurança, incluindo eventos adversos, ocorridos durante o uso de medicamentos/vacinas da GSK, entre em contato diretamente com o Departamento de Farmacovigilância da empresa pelo e-mail &lt;a href=&quot;mailto:farmacovigilancia@gsk.com&quot; target=&quot;_blank&quot;&gt;farmacovigilancia@gsk.com&lt;/a&gt; ou através do representante do grupo de empresas GSK. As marcas registradas pertencem ou são licenciadas ao grupo de empresas GSK.&lt;/p&gt;" data-popup-buttons="&lt;a class=&quot;button&quot; href=&quot;https://br.gsk.com/media/6289/nucala-solu%C3%A7%C3%A3o-injet%C3%A1vel.pdf&quot; target=&quot;_blank&quot;&gt;&lt;span&gt;Nucala Caneta Aplicadora&lt;/span&gt; &lt;img src=&quot;assets/images/white-arrow.svg&quot; /&gt;&lt;/a&gt;&lt;a class=&quot;button&quot; href=&quot;https://br.gsk.com/media/7579/nucala-p%C3%B3-liofilizado.pdf&quot; target=&quot;_blank&quot;&gt;&lt;span&gt;Nucala Pó Liofilizado&lt;/span&gt; &lt;img src=&quot;assets/images/white-arrow.svg&quot; /&gt;&lt;/a&gt;" data-footbutton-text="&lt;h3&gt;For Prescribing Information&lt;/h3&gt;&lt;p&gt;To view or download click on the below buttons for each product.&lt;/p&gt;"><img src="/assets/images/brazil.svg" alt=""><span>Brazil</span><img src="/assets/images/arrow-icon.svg" alt=""></a></li><li><a href="javascript:;" data-popup-content="&lt;p&gt;La información para prescribir completa de nuestros productos se encuentra disponible en nuestras páginas web: &lt;br&gt;Chile: &lt;a target=&quot;_blank&quot; href=&quot;http://www.gskpro.com/es-cl/productos&quot;&gt;www.gskpro.com/es-cl/productos&lt;/a&gt;&lt;br&gt;Mayor información de nuestros productos disponible a través de nuestro servicio de información médica: &lt;a  target=&quot;_blank&quot; href=&quot;mailto:mila@gsk.com&quot;&gt;mila@gsk.com&lt;/a&gt;.&lt;br&gt;Para reportar eventos adversos o quejas de producto contacte a GSK a los teléfonos/e-mail:&lt;br&gt;Chile: (56-2) 2382 9000 opción 4 o al correo electrónico &lt;a target=&quot;_blank&quot; href=&quot;mailto:farmacovigilancia.chile@gsk.com&quot;&gt;farmacovigilancia.chile@gsk.com&lt;/a&gt;.&lt;br&gt;Direcciones:&lt;br&gt;GlaxoSmithKline Chile Ltda.: Av. Andrés Bello 2457 - Piso 20 (Oficinas 2001, 2003 y 2004), Providencia, Santiago.&lt;br&gt;Material exclusivo para entregar a profesionales de la salud que están habilitados a prescribir y/o dispensar en Chile.&lt;br&gt;Derechos reservados para GSK. La reproducción completa o parcial de este material está prohibida.&lt;/p&gt;" data-popup-buttons="&lt;a class=&quot;button&quot; href=&quot;https://gskpro.com/content/dam/global/hcpportal/es_CL/PDFs/Homepage/products/Nucala/CL_IP_Nucala.pdf&quot; target=&quot;_blank&quot;&gt;&lt;span&gt;Nucala&lt;/span&gt; &lt;img src=&quot;assets/images/white-arrow.svg&quot; /&gt;&lt;/a&gt;" data-footbutton-text="&lt;h3&gt;For Prescribing Information&lt;/h3&gt;&lt;p&gt;To view or download click on the below button.&lt;/p&gt;"><img src="/assets/images/chile.svg" alt=""><span>Chile</span><img src="/assets/images/arrow-icon.svg" alt=""></a></li></ul></div><div class="col-lg-4"><ul><li><a href="javascript:;" data-popup-content="&lt;p&gt;Información para prescribir completa disponible a solicitud| Referencia(s) disponible(s) a solicitud&lt;/p&gt;&lt;p&gt;Material exclusivo para profesionales de la salud.&lt;/p&gt;&lt;p&gt;Si usted desea mayor información o reportar una situación clínica desfavorable ocurrida durante el uso de un producto de GlaxoSmithKline, favor comunicarse al teléfono 01 8000 11 86 86 o escribir al correo electrónico: &lt;a href=&quot;mailto:programa.dirmedica@gsk.com&quot;&gt;programa.dirmedica@gsk.com&lt;/a&gt;&lt;/p&gt;&lt;p&gt;GlaxoSmithKline Colombia S.A., Calle 26 # 69B-45 Edificio Bogotá Corporate Center Piso 9&lt;/p&gt;&lt;p&gt;Solicite mayor información científica de nuestros productos en nuestro servicio de información médica, a través del email mila@gsk.com&lt;/p&gt;&lt;p&gt;Material elaborado por GSK.&lt;/p&gt;&lt;p&gt;Nucala (Mepolizumab) 100mg POLVO PARA SOLUCIÓN INYECTABLE Registro Sanitario No: INVIMA 2019M-0018922 | Nucala Pluma (mepolizumab) solución inyectable 100mg/mL Registro sanitario No: INVIMA 2022MBT-0000061 |  POLVO PARA  2019M-0019227&lt;/p&gt;" data-popup-buttons="&lt;a class=&quot;button&quot; href=&quot;https://gskpro.com/es-co/login/login-link.html/?resource=%2Fcontent%2Fdam%2Fglobal%2Fhcpportal%2Fes_CO%2Fprotected%2Fproducts%2Fpdfs%2Fnucala%2FInformacion-para-prescribir-Nucala.pdf&quot; target=&quot;_blank&quot;&gt;&lt;span&gt;Nucala&lt;/span&gt; &lt;img src=&quot;assets/images/white-arrow.svg&quot; /&gt;&lt;/a&gt;" data-footbutton-text="&lt;h3&gt;For Prescribing Information&lt;/h3&gt;&lt;p&gt;To view or download click on the below button.&lt;/p&gt;"><img src="/assets/images/colombia.svg" alt=""><span>Colombia</span><img src="/assets/images/arrow-icon.svg" alt=""></a></li><li><a href="javascript:;" data-popup-content="&lt;p&gt;To report Adverse Event/s associated with the use of GSK product/s, please contact us via &lt;a href=&quot;mailto:saudi.safety@gsk.com&quot; target=&quot;_blank&quot;&gt;saudi.safety@gsk.com&lt;/a&gt;&lt;/p&gt;&lt;p&gt;For more information, please refer to the prescribing information or contact GlaxoSmithKline via &lt;a href=&quot;mailto:gcc.medinfo@gsk.com&quot; target=&quot;_blank&quot;&gt;gcc.medinfo@gsk.com&lt;/a&gt;&lt;/p&gt;&lt;p&gt;To report the Quality related product complaint/s associated with the use of GSK product/s, please contact us via &lt;a href=&quot;mailto:ksa.productqualitycomplaint@gsk.com&quot; target=&quot;_blank&quot;&gt;ksa.productqualitycomplaint@gsk.com&lt;/a&gt;&lt;/p&gt;&lt;p&gt;For Healthcare Professionals Only&lt;/p&gt;&lt;h3&gt;NUCALA Safety Information&lt;/h3&gt;&lt;p&gt;Contraindications: Hypersensitivity to mepolizumab or to any of the excipients.&lt;/p&gt;&lt;h3&gt;Adverse reactions:&lt;/h3&gt;&lt;p&gt;Adverse reactions with Nucala with ≥3% incidence and more common than placebo in patients with severe asthma (in the 2 confirmatory efficacy and safety trials): headache, injection site reaction, back pain, fatigue, influenza, urinary tract infection, abdominal pain upper, pruritus, eczema, muscle spasms.&lt;/p&gt;&lt;p&gt;Adverse reactions with Nucala with ≥3% of NUCALA-treated patients and more frequently than in patients treated with placebo in the CRSwNP trial: oropharyngeal pain, arthralgia, abdominal pain, upper, diarrhea, pyrexia, nasal dryness, rash.&lt;/p&gt;&lt;p&gt;Adverse reactions that occurred more frequently than in patients treated with placebo in the EGPA trial: systemic (allergic and non-allergic) reactions, injection site reactions.&lt;/p&gt;&lt;p&gt;Adverse reactions that occurred more frequently than in patients treated with placebo in the HES trial: injection site reactions.&lt;/p&gt;&lt;h3&gt;Nucala lyophilized powder:&lt;/h3&gt;&lt;p&gt;- Very common (≥1/10): headache.&lt;br&gt;- Common (≥1/100 to &lt; 1/10): lower respiratory tract infection, urinary tract infection.&lt;br&gt;&lt;strong&gt;Reference&lt;/strong&gt;: 1. Nucala (solution for injection in a pre-filled pen) local prescribing information based on US CPI version 29 July 2021; 2. Nucala (solution for injection in a pre-filled syringe) local prescribing information based on US CPI version 29 July 2021. 3. Nucala (powder for solution for injection) local prescribing information GDS12/IPI12.&lt;/p&gt;" data-popup-buttons="&lt;a class=&quot;button&quot; href=&quot;https://assets.gskinternet.com/pharma/GSKpro/Saudi/Nucala/nucala_updated_saudi_spc_2021.pdf&quot; target=&quot;_blank&quot;&gt;&lt;span&gt;Nucala Pre-filled Pen&lt;/span&gt; &lt;img src=&quot;assets/images/white-arrow.svg&quot; /&gt;&lt;/a&gt;&lt;a class=&quot;button&quot; href=&quot;https://assets.gskinternet.com/pharma/GSKpro/Saudi/Nucala/nucala_pfs_spc_version_29_07_2021.pdf&quot; target=&quot;_blank&quot;&gt;&lt;span&gt;Nucala Pre-filled Syringe&lt;/span&gt; &lt;img src=&quot;assets/images/white-arrow.svg&quot; /&gt;&lt;/a&gt;" data-footbutton-text="&lt;h3&gt;For Prescribing Information&lt;/h3&gt;&lt;p&gt;To view or download click on the below buttons for each product.&lt;/p&gt;"><img src="/assets/images/saudi-arabia.svg" alt=""><span>KSA </span><img src="/assets/images/arrow-icon.svg" alt=""></a></li><li><a href="javascript:;" data-popup-content="&lt;p&gt;To report Adverse Event/s associated with the use of GSK product/s, please contact us via &lt;a target=&quot;_blank&quot; href=&quot;mailto:gulf.safety@gsk.com&quot;&gt;gulf.safety@gsk.com&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;To report quality complaint/s associated with the use of GSK product/s, please contact us via &lt;a href=&quot;mailto:Gulf.ProductQualityComplaints@gsk.com&quot; target=&quot;_blank&quot;&gt;Gulf.ProductQualityComplaints@gsk.com&lt;/a&gt;&lt;/p&gt;&lt;p&gt;For more information, please refer to the prescribing information or contact GlaxoSmithKline via &lt;a href=&quot;mailto:gcc.medinfo@gsk.com&quot; target=&quot;_blank&quot;&gt;gcc.medinfo@gsk.com&lt;/a&gt;.&lt;/p&gt;" data-popup-buttons="&lt;a class=&quot;button&quot; href=&quot;https://gskpro.com/content/dam/global/hcpportal/en_XG/products/nucala_mt/pdf/pi_nucala_uae_oman_qatar_kuwait_and_bahrain_pi_9494.pdf&quot; target=&quot;_blank&quot;&gt;&lt;span&gt;Nucala Vial&lt;/span&gt; &lt;img src=&quot;assets/images/white-arrow.svg&quot; /&gt;&lt;/a&gt;" data-footbutton-text="&lt;h3&gt;For Prescribing Information&lt;/h3&gt;&lt;p&gt;To view or download click on the below button.&lt;/p&gt;"><img src="/assets/images/kuwait.svg" alt=""><span>Kuwait</span><img src="/assets/images/arrow-icon.svg" alt=""></a></li><li><a href="javascript:;" data-popup-content="&lt;p&gt;Para consultar la información para prescribir favor de dirigirse al sitio www.gskpro.com.mx. También puede solicitarla al teléfono 1800 APOYAME (276-9263) o directamente al representante médico que lo visita.&lt;/p&gt;&lt;p&gt;Este micrositio está destinado a México. Exclusivo para profesionales de la salud.&lt;/p&gt;&lt;p&gt;Su privacidad es importante para nosotros. Por favor, lea nuestra política de privacidad.&lt;/p&gt;&lt;p&gt;La información existente en este mensaje y en los archivos/ligas anexos es para uso exclusivo de profesionales de la salud.&lt;/p&gt;&lt;p&gt;En caso de que usted no sea el destinatario, la lectura, divulgación, reproducción, distribución o copia del contenido de éste mensaje están prohibidas y podría generar acción legal en su contra. Si usted ha recibido esta comunicación por error, por favor notifíquenoslo inmediatamente  a &lt;a href=&quot;mailto:mx.contacto@gsk.com&quot; target=&quot;_blank&quot;&gt;mx.contacto@gsk.com&lt;/a&gt;&lt;/p&gt;&lt;p&gt; Si necesita más asistencia, comuníquese al 800 276 9263 o bien en nuestro correo electrónico: &lt;a href=&quot;mailto:mx.contacto@gsk.com&quot; target=&quot;_blank&quot;&gt;mx.contacto@gsk.com&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;México, S.A. de C.V. Avenida Real Mayorazgo, No. exterior 130, No. Interior Piso 20, Colonia Xoco,&lt;/p&gt;&lt;p&gt;Alcaldía Benito Juárez,&lt;br&gt;CP 03330, Ciudad de México. Página web de GSK para profesionales de la salud: &lt;a target=&quot;_blank&quot; href=&quot;http://gskpro.com/es-mx&quot;&gt;gskpro.com/es-mx&lt;/a&gt;&lt;/p&gt;" data-popup-buttons="&lt;a class=&quot;button&quot; href=&quot;https://gskpro.com/content/dam/global/hcpportal/es_MX/unprotected/products/Nucala/Pdf/IPP-A-Nucala-GDS05_IPI05-02-Jun-2016.pdf&quot; target=&quot;_blank&quot;&gt;&lt;span&gt;Nucala Solucion&lt;/span&gt; &lt;img src=&quot;assets/images/white-arrow.svg&quot; /&gt;&lt;/a&gt;" data-footbutton-text="&lt;h3&gt;Información para prescribir amplia (IPPA)&lt;/h3&gt;&lt;p&gt;Para ver o descargar la IPPA dar clic en el botón&lt;/p&gt;"><img src="/assets/images/mexico.svg" alt=""><span>Mexico</span><img src="/assets/images/arrow-icon.svg" alt=""></a></li></ul></div><div class="col-lg-4"><ul><li><a href="javascript:;" data-popup-content="&lt;p&gt;For more information, please refer to the prescribing information or contact GlaxoSmithKline via &lt;a target=&quot;_blank&quot; href=&quot;mailto:gcc.medinfo@gsk.com.&quot;&gt;gcc.medinfo@gsk.com.&lt;/a&gt;&lt;/p&gt;&lt;p&gt;To report Adverse Event/s associated with the use of GSK product/s, please contact us via &lt;a href=&quot;mailto:gulf.safety@gsk.com&quot; target=&quot;_blank&quot;&gt;gulf.safety@gsk.com&lt;/a&gt;&lt;/p&gt;&lt;p&gt;To report quality complaint/s associated with the use of GSK product/s, please contact us via &lt;a target=&quot;_blank&quot; href=&quot;mailto:Gulf.ProductQualityComplaints@gsk.com&quot;&gt;Gulf.ProductQualityComplaints@gsk.com&lt;/a&gt;.&lt;/p&gt;&lt;table&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;Department of Pharmacovigilance &amp;amp; Drug Information&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td align=&quot;right&quot; style=&quot;text-align:right&quot;&gt;&lt;p&gt; داﺋرة اﻟﺗﯾﻘظ و اﻟﻣﻌﻠوﻣﺎت اﻟدواﺋﯾﺔ&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;Directorate General of Pharmaceutical &lt;br&gt;Affairs &amp;amp; Drug Control&lt;/p&gt; &lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td align=&quot;right&quot; style=&quot;text-align:right&quot;&gt;&lt;p&gt; اﻟﻣدﯾرﯾﺔ اﻟﻌﺎﻣﺔ ﻟﻠﺻﯾدﻟﺔ و اﻟرﻗﺎﺑﺔ اﻟدواﺋﯾﺔ&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;Ministry of Health, Sultanate of Oman&lt;/p&gt; &lt;/td&gt;&lt;td&gt;&lt;/td&gt;&lt;td align=&quot;right&quot; style=&quot;text-align:right&quot;&gt;&lt;p&gt; وزارة اﻟﺻﺣﺔ, ﺳﻠطﻧﺔ ﻋﻣﺎن&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;Phone Nos.&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;0096822357687 / 0096822357686&lt;/p&gt;&lt;/td&gt;&lt;td align=&quot;right&quot; style=&quot;text-align:right&quot;&gt; &lt;p&gt; هاتف&lt;/p&gt;    &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;Fax&lt;/p&gt;&lt;p&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&lt;p&gt;0096822358489&lt;/p&gt;&lt;/td&gt;&lt;td align=&quot;right&quot; style=&quot;text-align:right&quot;&gt;&lt;p&gt;ﻓﺎﻛس &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;Email&lt;/p&gt; &lt;/td&gt;&lt;td&gt;&lt;p&gt;&lt;a href=&quot;mailto:pharma-vigil@moh.gov.om&quot;&gt;pharma-vigil@moh.gov.om&lt;/a&gt;&lt;/p&gt;&lt;/td&gt;&lt;td align=&quot;right&quot; style=&quot;text-align:right&quot;&gt;&lt;p&gt;البريد الالكتروني &lt;/p&gt; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;p&gt;Website&lt;/p&gt; &lt;/td&gt;&lt;td&gt;&lt;p&gt;&lt;a href=&quot;https://www.moh.gov.om&quot; target=&quot;_blank&quot;&gt;www.moh.gov.om&lt;/a&gt;&lt;/p&gt;&lt;/td&gt;&lt;td align=&quot;right&quot; style=&quot;text-align:right&quot;&gt;&lt;p&gt;الموقع الالكتروني&lt;p&gt; &lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;" data-popup-buttons="&lt;a class=&quot;button&quot; href=&quot;https://gskpro.com/content/dam/global/hcpportal/en_XG/products/nucala_mt/pdf/pi_nucala_uae_oman_qatar_kuwait_and_bahrain_pi_9494.pdf&quot; target=&quot;_blank&quot;&gt;&lt;span&gt;Nucala Vial&lt;/span&gt; &lt;img src=&quot;assets/images/white-arrow.svg&quot; /&gt;&lt;/a&gt;&lt;a class=&quot;button&quot; href=&quot;https://gskpro.com/content/dam/global/hcpportal/en_XG/products/nucala_mt/pdf/updated_nucala_pi_for_triple_therapy_indication_uae_oman_bahrain_and_qatar_july_23.pdf&quot; target=&quot;_blank&quot;&gt;&lt;span&gt;Nucala PFP/PFS&lt;/span&gt; &lt;img src=&quot;assets/images/white-arrow.svg&quot; /&gt;&lt;/a&gt;" data-footbutton-text="&lt;h3&gt;For Prescribing Information&lt;/h3&gt;&lt;p&gt;To view or download click on the below buttons for each product.&lt;/p&gt;"><img src="/assets/images/oman.svg" alt=""><span>Oman</span><img src="/assets/images/arrow-icon.svg" alt=""></a></li><li><a href="javascript:;" data-popup-content="&lt;p&gt;To report Adverse Event/s associated with the use of GSK product/s, please contact us via &lt;a href=&quot;mailto:gulf.safety@gsk.com&quot; target=&quot;_blank&quot;&gt;gulf.safety@gsk.com&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;To report quality complaint/s associated with the use of GSK product/s, please contact us via &lt;a target=&quot;_blank&quot; href=&quot;mailto:Gulf.ProductQualityComplaints@gsk.com&quot;&gt;Gulf.ProductQualityComplaints@gsk.com&lt;/a&gt;&lt;/p&gt;&lt;p&gt;This email is intended for Gulf countries healthcare professionals only.&lt;/p&gt;&lt;p&gt;For more information, please refer to the prescribing information or contact GlaxoSmithKline via &lt;a href=&quot;mailto:gcc.medinfo@gsk.com&quot; target=&quot;_blank&quot;&gt;gcc.medinfo@gsk.com&lt;/a&gt;.&lt;/p&gt;" data-popup-buttons="&lt;a class=&quot;button&quot; href=&quot;https://gskpro.com/content/dam/global/hcpportal/en_XG/products/nucala_mt/pdf/pi_nucala_uae_oman_qatar_kuwait_and_bahrain_pi_9494.pdf&quot; target=&quot;_blank&quot;&gt;&lt;span&gt;Nucala Vial&lt;/span&gt; &lt;img src=&quot;assets/images/white-arrow.svg&quot; /&gt;&lt;/a&gt;&lt;a class=&quot;button&quot; href=&quot;https://gskpro.com/content/dam/global/hcpportal/en_XG/products/nucala_mt/pdf/updated_nucala_pi_for_triple_therapy_indication_uae_oman_bahrain_and_qatar_july_23.pdf&quot; target=&quot;_blank&quot;&gt;&lt;span&gt;Nucala PFP/PFS&lt;/span&gt; &lt;img src=&quot;assets/images/white-arrow.svg&quot; /&gt;&lt;/a&gt;" data-footbutton-text="&lt;h3&gt;For Prescribing Information&lt;/h3&gt;&lt;p&gt;To view or download click on the below buttons for each product.&lt;/p&gt;"><img src="/assets/images/qatar.svg" alt=""><span>Qatar</span><img src="/assets/images/arrow-icon.svg" alt=""></a></li><li><a href="javascript:;" data-popup-content="&lt;p&gt;To report Adverse Event/s associated with the use of GSK product/s, please contact us via &lt;a href=&quot;mailto:gulf.safety@gsk.com&quot; target=&quot;_blank&quot;&gt;gulf.safety@gsk.com&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;To report quality complaint/s associated with the use of GSK product/s, please contact us via  &lt;a href=&quot;mailto:Gulf.ProductQualityComplaints@gsk.com&quot; target=&quot;_blank&quot;&gt;Gulf.ProductQualityComplaints@gsk.com&lt;/a&gt;&lt;/p&gt;&lt;p&gt;This email is intended for Gulf countries healthcare professionals only.&lt;/p&gt;&lt;p&gt;For more information, please refer to the prescribing information or contact GlaxoSmithKline via &lt;a href=&quot;mailto:gcc.medinfo@gsk.com&quot; target=&quot;_blank&quot;&gt;gcc.medinfo@gsk.com&lt;/a&gt;.&lt;/p&gt;" data-popup-buttons="&lt;a class=&quot;button&quot; href=&quot;https://gskpro.com/content/dam/global/hcpportal/en_XG/products/nucala_mt/pdf/pi_nucala_uae_oman_qatar_kuwait_and_bahrain_pi_9494.pdf&quot; target=&quot;_blank&quot;&gt;&lt;span&gt;Nucala Vial&lt;/span&gt; &lt;img src=&quot;assets/images/white-arrow.svg&quot; /&gt;&lt;/a&gt;&lt;a class=&quot;button&quot; href=&quot;https://gskpro.com/content/dam/global/hcpportal/en_XG/products/nucala_mt/pdf/updated_nucala_pi_for_triple_therapy_indication_uae_oman_bahrain_and_qatar_july_23.pdf&quot; target=&quot;_blank&quot;&gt;&lt;span&gt;Nucala PFP/PFS&lt;/span&gt; &lt;img src=&quot;assets/images/white-arrow.svg&quot; /&gt;&lt;/a&gt;" data-footbutton-text="&lt;h3&gt;For Prescribing Information&lt;/h3&gt;&lt;p&gt;To view or download click on the below buttons for each product.&lt;/p&gt;"><img src="/assets/images/uae.svg" alt=""><span>UAE </span><img src="/assets/images/arrow-icon.svg" alt=""></a></li></ul></div><div class="col-lg-12"><ul><li><a class="videoButton bg-orange color-white" href="javascript:;" data-popup-content="&lt;video controls autoplay&gt;&lt;source src='https://gsk-nexus.s3.eu-north-1.amazonaws.com/gsk-nexus-video.mp4' type='video/mp4'&gt;&lt;/video&gt;"><span class="text-center">Watch Nexus Video</span></a></li></ul></div></div></div></div></div></div></section></main><footer class="d-flex"><p class="text-center">You can learn about the information that we may process about you, and how we use your information, <a class="" href="https://privacy.gsk.com/en-gb/privacy-notice/general/" target="_blank">click here</a>. You can also view our terms of use, and policy statement <a class="" href="https://www.gsk.com/en-gb/terms-of-use/" target="_blank">click here</a>, Cookie policy <a class="" href="https://www.gsk.com/en-gb/cookie-policy/" target="_blank">click here</a>. Trademarks are owned by or licensed to the GSK group of companies.<br>Copyright © GlaxoSmithKline 2023.</p><a class="footLogo" href=""><img src="/assets/images/gsk-logo.svg" alt=""></a></footer><script src="./assets/scripts/app.js"></script><script>//- alert();</script></body></html>